While changes in serum levels of CXCL11 and MMP-13 were significantly associated with longitudinal progression of RA-ILD in univariate analyses, baseline age and RF were also associated with the long-term outcomes of RA-ILD. The gene discussed is MMP13; the disease is rheumatoid arthritis.